Showing 7451-7460 of 20412 results for "".
Amivantamab Monotherapy or in Combination With Paclitaxel in Previously Treated Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: OrigAMI-4 Study Results
https://reachmd.com/clinical-practice/oncology-hematology/amivantamab-monotherapy-or-in-combination-with-paclitaxel-in-previously-treated-recurrent-or-metastatic-head-and-neck-squamous-cell-carcinoma-origami-4-study-results/39780/In the phase 1b/2 OrigAMI-4 trial, amivantamab alone or with paclitaxel showed strong and durable responses in previously treated recurrent or metastatic HNSCC.From Pathway to Patient: Clinical Advances in PI3K-Directed Therapy for HR+/HER2- mBC
https://reachmd.com/programs/cme/From-Pathway-to-Patient-Clinical-Advances-in-PI3K-Directed-Therapy-for-HR-HER2-mBC/35975/Join Drs. Jhaveri and Kalinsky and get up to speed on the latest data on PI3K-directed therapies and their role in the treatment paradigm for HR+, HER2- mBC.Newly Diagnosed Multiple Myeloma: The Prognostic Significance of Lymphopenia
https://reachmd.com/programs/project-oncology/newly-diagnosed-multiple-myeloma-the-prognostic-significance-of-lymphopenia/30047/A recent study examined how absolute lymphocyte count correlates with overall survival in newly diagnosed multiple myeloma—here’s what it found.Zilucoplan: A Promising Potential Treatment for Myasthenia Gravis
https://reachmd.com/programs/neurofrontiers/zilucoplan-a-promising-potential-treatment-for-myasthenia-gravis/26392/Dive into a recent study that suggests zilucoplan could help treat MG symptoms.A Guide for Off-Label Use of Treatments for COVID-19 from the ASHP
https://reachmd.com/programs/the-drug-report/a-guide-for-off-label-use-of-treatments-for-covid-19-from-the-ashp/11412/Recommendations for using experimental treatments during the COVID-19 pandemic were recently published. Here’s what they say.Overcoming Vaccine Hesitancy: Persuasive Conversation Strategies and Tips
https://reachmd.com/programs/medical-industry-feature/vaccine-hesitancy-conversation-strategies/56685/Here are some tips and strategies for addressing vaccine hesitancy with patients.Breaking the Line: Moving Bispecific Antibodies Upstream in Treating Multiple Myeloma
https://reachmd.com/programs/cme/breaking-the-line-moving-bispecific-antibodies-upstream-in-treating-multiple-myeloma/49265/Learn how early-line bispecific antibodies are reshaping multiple myeloma treatment, supported by emerging efficacy and safety data from key clinical trials.Advancing Care for Refractory Chronic Cough: Diagnostics and Emerging Therapies
https://reachmd.com/programs/deep-breaths-updates-chest/advancing-care-for-refractory-chronic-cough-diagnostics-and-emerging-therapies/32874/Refractory chronic cough (RCC) is a debilitating condition that is often misunderstood and underdiagnosed, leaving patients with persistent symptoms despite standard treatment. Hear from Drs. Michael Ghobrial, Anju Peters, and Michael Blaiss as they clarify the definition of RCC, outline essential dNeuro-Ophthalmology Notions: The Optic Nerve as Topographic Marker in the 2024 McDonald Diagnostic Criteria for Multiple Sclerosis
https://reachmd.com/diseases-diagnoses/ms-immune-disorders/neuro-ophthalmology-notions-the-optic-nerve-as-topographic-marker-in-the-2024-mcdonald-diagnostic-criteria-for-multiple-sclerosis/35447/Neuro-ophthalmic evaluations assist in early diagnosis of multiple sclerosis.Best Practices in Fluid Management During CKRT
https://reachmd.com/programs/kdigo-conversations-nephrology/best-practices-in-fluid-management-during-ckrt/14169/How does kidney replacement therapy work? And what are the challenges?